Headlines

Eli Lilly (LLY) and Hims & Hers Health (HIMS) announce an agreement to help expand access to Zepbound (tirzepatide) and Foundayo (orforglipron)

Newsquawk Staff ·

Eli Lilly (LLY) and Hims & Hers Health (HIMS) announce an agreement to help expand access to Zepbound (tirzepatide) and Foundayo (orforglipron)

Related headlines